Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation

Background There is significant interest in NO pathway modulators, specifically type 5 phosphodiesterase inhibitors (PDE5is), to treat patients with a Fontan circulation. Trials, however, have had mixed results. The relationship between the NO pathway and clinical status in patients with Fontan circ...

Full description

Bibliographic Details
Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Ari Cedars, Cedric Manlhiot, Bhargava Kumar Chinni, Alexander R. Opotowsky, Kristian Becker, Anne Le, Pratik Khare, Jong Love Ko, Allen Everett, Shelby Kutty, Mark W. Russell, R. Mark Payne, Andrew M. Atz, Brian W. McCrindle, Rahul H. Rathod, Matthew Lewis, David Goldberg, Kevin Hill, Michelle Ploutz, Jon Detterich, Kurt Schumacher, Robert Whitehill, Daniel J. Penny, Mark Cartoski, Rachel Sullivan, Matthew Files, Ruchira Garg, Jonathan Wagner, Roni Jacobsen, Todd Nowlen, Scott Fletcher, Jennifer Conway, Gi Boem Kim, Fred Wu, Victor Zak
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Subjects:	Fontan metabolomics nitric oxide type 5 phosophodiesterase inhibitor
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.038061

Similar Items

Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL Trial
by: David J. Goldberg, et al.
Published: (2025-08-01)

One Ventricle, 3000 Proteins: Unraveling the Molecular Landscape of the Fontan Circulation
by: Jennifer P. Woo, et al.
Published: (2025-05-01)

Clinical complications of liver disease in adults after the Fontan operation
by: Bhavesh Patel, et al.
Published: (2022-06-01)

Fontan-Associated Liver Disease: A Review
by: Luis Téllez, et al.
Published: (2018-03-01)

Novel lateral tunnel Fontan operation in children promotes continued pathway growth into adulthoodCentral MessagePerspective
by: Mary C. Marciniak, MMS, et al.
Published: (2025-02-01)

Gut Dysbiosis in Patients With Fontan Circulation
by: Hideo Ohuchi, et al.
Published: (2024-09-01)

Prevalence of hepatic dysfunction in paediatric patients with Fontan circulation
by: Amal Mahmoud El-Sisi, et al.
Published: (2024-05-01)

Novel immunologic mechanisms for Fontan-associated liver disease
by: Austin Angelotti, et al.
Published: (2025-03-01)

Staged Acclimatization in a Failing Fontan by AFR in AFR
by: Jenny E. Zablah, MD, et al.
Published: (2023-06-01)

Atrial Arrhythmias in Adults with Fontan Palliation
by: Matthew Laubham, et al.
Published: (2023-07-01)

Overcoming borders: International cooperation in re-use and re-interpretation of omics data in Fontan circulation
by: Miriam Michel, et al.
Published: (2025-06-01)

Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study
by: David J. Goldberg, et al.
Published: (2017-05-01)

Uso de Algoritmo no Gerenciamento do Estímulo Ventricular em Paciente com Circulaçao de Fontan
by: Decio Cavalet-Soares Abuchaim, et al.
Published: (2009-10-01)

Heart transplantation after Fontan operationCentral Message
by: Igor E. Konstantinov, MD, PhD, FRACS, et al.
Published: (2022-06-01)

Obstructed Extracardiac Fontan Conduit in an 18-Year-Old with Dextrocardia: A Unique Solution to A Unique Anatomy
by: Ali H. Mashadi, et al.
Published: (2024-06-01)

Alterations in Liver Perfusion in Adults With Fontan Circulation as Assessed by Dual Cholate Clearance
by: Yuli Y. Kim, et al.
Published: (2025-04-01)

Un boceto original de Manuel Fontanals
by: Elisa Lozano
Published: (2018-09-01)

Characterization and z-score calculation of cardiovascular magnetic resonance imaging parameters in patients after the Fontan operation: A Fontan Outcome Registry using Cardiovascular Magnetic Resonance Examinations study
by: Tarek Alsaied, et al.
Published: (2024-01-01)

"Geheimnisse [...] und Anspielungen" oder Caroline und Effi von Briest. "Namen-anspielung" und Proto-emanzipation in Theodor Fontanes Roman
by: Michael Schmidt
Published: (1998-01-01)

Effect of liver abnormalities on mortality in Fontan patients: a systematic review and meta-analysis
by: Xiang Liu, et al.
Published: (2024-07-01)

Fontan procedure with extracardiac conduit in pediatrics and children: Short-term results
by: Waleed El-Awady, et al.
Published: (2022-01-01)

A retrospective review of sildenafil in the Australia and New Zealand Fontan registry: indications and treatment responses
by: Phidias Rueter, et al.
Published: (2024-06-01)

It’s not just the heart: respiratory limitations to constant-load exercise in adult Fontan patients and potential implications for rehabilitation
by: Kyle G. P. J. M. Bolye, et al.
Published: (2024-02-01)

Autonomous Fontan pump: Computational feasibility studyCentral MessagePerspective
by: Mark D. Rodefeld, MD, et al.
Published: (2024-10-01)

Role of Cardiovascular Imaging in the Follow-Up of Patients with Fontan Circulation
by: Sara Moscatelli, et al.
Published: (2022-11-01)

Association of Fontan Pathophysiology With Plasma Bile Acids
by: Ashish H. Shah, MD, MD-Research, et al.
Published: (2025-02-01)

Tadalafil and exercise capacity after fontan operation
by: Zahra Khajali, et al.
Published: (2018-01-01)

Investigation of a chronic single-stage sheep Fontan modelCentral MessagePerspective
by: John M. Kelly, MD, et al.
Published: (2024-10-01)

The long-term effects of the fenestration in patients with extracardiac Fontan circulation—a multicenter Korean cohort study based on national Fontan registry
by: Hoon Ko, et al.
Published: (2024-05-01)

The increasing utilization of ventricular assist devices in fontan failure
by: Darren Turner, MD, et al.
Published: (2025-08-01)

Correlation between Olink and SomaScan proteomics platforms in adults with a Fontan circulation
by: Ismael Z. Assi, et al.
Published: (2025-06-01)

Hemodynamic assessment in transcatheter fenestration closure in patients after Fontan operation
by: E. Levunlieva, et al.
Published: (2024-05-01)

Predictive factors contributing to prolonged recovery in patients after Fontan operation
by: Yixiao Song, et al.
Published: (2022-08-01)

Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease
by: Paweł Skorek, et al.
Published: (2025-07-01)

Hepatocellular carcinoma diagnosed in a patient who had Fontan operation 30 years ago: a case report
by: Moon Haeng Hur, et al.
Published: (2022-09-01)

Social life in adult patients after Fontan procedure
by: Mohammed S. Alhabdan, et al.
Published: (2022-10-01)

Manajemen Anestesi Prosedur Fontan
by: Akhmad Ridconi, et al.
Published: (2017-11-01)

Retroperitoneal paraganglioma in a patient with Fontan: The hypoxia connection
by: Shriprasad R Deshpande, et al.
Published: (2018-01-01)

Performing modified fontan before six years of age leads to superior long-term exercise capacity
by: Panagiotis G. Sfyridis, et al.
Published: (2020-09-01)

Systolic dysfunction of systemic ventricle in patients who underwent a Fontan operation
by: Taliha Öner, et al.
Published: (2019-12-01)